WallStreetZenWallStreetZen

NASDAQ: AXSM
Axsome Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for AXSM

Based on 12 analysts offering 12 month price targets for Axsome Therapeutics Inc

Min Forecast
$144.00+6.72%
Avg Forecast
$175.50+30.07%
Max Forecast
$205.00+51.93%

Should I buy or sell AXSM stock?

Based on 12 analysts offering ratings for Axsome Therapeutics Inc.

Strong Buy
Strong Buy
7 analysts 58.33%
Buy
5 analysts 41.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although AXSM's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates AXSM as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their AXSM stock forecasts and price targets.

AXSM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-04Find Out Why
lockedlocked$00.00+00.00%2025-11-04
lockedlocked$00.00+00.00%2025-11-04
lockedlocked$00.00+00.00%2025-11-04
lockedlocked$00.00+00.00%2025-11-04
Needham
Top 1%
100
BuyReiterates$154.00+14.13%2025-11-04
B. Riley Securities
Bottom 26%
26
Strong BuyInitiates Coverage On$179.00+32.66%2025-10-01
UBS
Top 19%
82
Strong BuyMaintains$144.00+6.72%2025-08-06
Bank of America
Top 21%
80
Strong BuyMaintains$176.00+30.44%2025-08-05
Oppenheimer
Bottom 44%
44
BuyInitiates Coverage On$185.00+37.11%2025-06-03

1 of 2

Forecast return on equity

Is AXSM forecast to generate an efficient return?

Company
886.95%
Industry
248.17%
Market
229.97%
AXSM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AXSM forecast to generate an efficient return on assets?

Company
97.71%
Industry
108.07%
AXSM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AXSM earnings per share forecast

What is AXSM's earnings per share in the next 3 years based on estimates from 22 analysts?

Avg 1 year Forecast
-$3.68
Avg 2 year Forecast
$0.83
Avg 3 year Forecast
$8.13

AXSM revenue forecast

What is AXSM's revenue in the next 3 years based on estimates from 22 analysts?

Avg 1 year Forecast
$631.2M+12.46%
Avg 2 year Forecast
$975.0M+73.71%
Avg 3 year Forecast
$1.5B+164.4%
AXSM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AXSM revenue growth forecast

How is AXSM forecast to perform vs Biotechnology companies and vs the US market?

Company
37.26%
Industry
108.49%
Market
26.28%
AXSM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AXSM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AXSM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AXSM$134.93$175.50+30.07%Strong Buy
RYTM$104.99$116.42+10.88%Strong Buy
NUVL$91.02$122.36+34.44%Strong Buy
CYTK$59.62$80.42+34.88%Strong Buy
MRUS$95.04$97.39+2.47%Hold
View Top Biotech Stocks

Axsome Therapeutics Stock Forecast FAQ

Is Axsome Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NASDAQ: AXSM) stock is to Strong Buy AXSM stock.

Out of 12 analysts, 7 (58.33%) are recommending AXSM as a Strong Buy, 5 (41.67%) are recommending AXSM as a Buy, 0 (0%) are recommending AXSM as a Hold, 0 (0%) are recommending AXSM as a Sell, and 0 (0%) are recommending AXSM as a Strong Sell.

If you're new to stock investing, here's how to buy Axsome Therapeutics stock.

What is AXSM's earnings growth forecast for 2025-2027?

(NASDAQ: AXSM) Axsome Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 36.37%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.39%.

Axsome Therapeutics's earnings in 2025 is -$229,527,000.On average, 22 Wall Street analysts forecast AXSM's earnings for 2025 to be -$185,407,607, with the lowest AXSM earnings forecast at -$210,462,689, and the highest AXSM earnings forecast at -$148,319,028. On average, 22 Wall Street analysts forecast AXSM's earnings for 2026 to be $42,003,812, with the lowest AXSM earnings forecast at -$146,731,030, and the highest AXSM earnings forecast at $211,894,408.

In 2027, AXSM is forecast to generate $409,678,319 in earnings, with the lowest earnings forecast at $77,070,844 and the highest earnings forecast at $819,407,051.

What is AXSM's revenue growth forecast for 2025-2027?

(NASDAQ: AXSM) Axsome Therapeutics's forecast annual revenue growth rate of 37.26% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 108.49%, and while it is forecast to beat the US market's average forecast revenue growth rate of 26.28%.

Axsome Therapeutics's revenue in 2025 is $561,263,000.On average, 22 Wall Street analysts forecast AXSM's revenue for 2025 to be $31,821,466,621, with the lowest AXSM revenue forecast at $29,697,077,971, and the highest AXSM revenue forecast at $33,925,186,088. On average, 22 Wall Street analysts forecast AXSM's revenue for 2026 to be $49,151,315,747, with the lowest AXSM revenue forecast at $38,411,911,048, and the highest AXSM revenue forecast at $57,672,060,160.

In 2027, AXSM is forecast to generate $74,812,357,760 in revenue, with the lowest revenue forecast at $57,117,521,120 and the highest revenue forecast at $98,808,774,400.

What is AXSM's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: AXSM) forecast ROA is 97.71%, which is lower than the forecast US Biotechnology industry average of 108.07%.

What is AXSM's Price Target?

According to 12 Wall Street analysts that have issued a 1 year AXSM price target, the average AXSM price target is $175.50, with the highest AXSM stock price forecast at $205.00 and the lowest AXSM stock price forecast at $144.00.

On average, Wall Street analysts predict that Axsome Therapeutics's share price could reach $175.50 by Nov 4, 2026. The average Axsome Therapeutics stock price prediction forecasts a potential upside of 30.07% from the current AXSM share price of $134.93.

What is AXSM's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: AXSM) Axsome Therapeutics's current Earnings Per Share (EPS) is -$4.67. On average, analysts forecast that AXSM's EPS will be -$3.68 for 2025, with the lowest EPS forecast at -$4.17, and the highest EPS forecast at -$2.94. On average, analysts forecast that AXSM's EPS will be $0.83 for 2026, with the lowest EPS forecast at -$2.91, and the highest EPS forecast at $4.20. In 2027, AXSM's EPS is forecast to hit $8.13 (min: $1.53, max: $16.25).

What is AXSM's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: AXSM) forecast ROE is 886.95%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.